BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 21576642)

  • 1. Characteristics and outcomes of breast cancer in women with and without a history of radiation for Hodgkin's lymphoma: a multi-institutional, matched cohort study.
    Elkin EB; Klem ML; Gonzales AM; Ishill NM; Hodgson D; Ng AK; Marks LB; Weidhaas J; Freedman GM; Miller RC; Constine LS; Myrehaug S; Yahalom J
    J Clin Oncol; 2011 Jun; 29(18):2466-73. PubMed ID: 21576642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening mammography for young women treated with supradiaphragmatic radiation for Hodgkin's lymphoma.
    Lee L; Pintilie M; Hodgson DC; Goss PE; Crump M
    Ann Oncol; 2008 Jan; 19(1):62-7. PubMed ID: 17878177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathologic features of breast cancers diagnosed in women treated with prior radiation therapy for Hodgkin lymphoma: Results from a population-based cohort.
    Wong SM; Ajjamada L; Weiss AC; Prakash I; Skamene S; Boileau JF; Pollak MN; Basik M
    Cancer; 2022 Apr; 128(7):1365-1372. PubMed ID: 34919263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma.
    Travis LB; Hill D; Dores GM; Gospodarowicz M; van Leeuwen FE; Holowaty E; Glimelius B; Andersson M; Pukkala E; Lynch CF; Pee D; Smith SA; Van't Veer MB; Joensuu T; Storm H; Stovall M; Boice JD; Gilbert E; Gail MH
    J Natl Cancer Inst; 2005 Oct; 97(19):1428-37. PubMed ID: 16204692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secondary Breast Cancer Risk by Radiation Volume in Women With Hodgkin Lymphoma.
    Conway JL; Connors JM; Tyldesley S; Savage KJ; Campbell BA; Zheng YY; Hamm J; Pickles T
    Int J Radiat Oncol Biol Phys; 2017 Jan; 97(1):35-41. PubMed ID: 27979454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Locoregional treatment for breast carcinoma after Hodgkin's lymphoma: the breast conservation option.
    Haberer S; Belin L; Le Scodan R; Kirova YM; Savignoni A; Stevens D; Moisson P; Decaudin D; Pierga JY; Reyal F; Campana F; Fourquet A; Bollet MA
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e145-52. PubMed ID: 21605948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast cancer after treatment of Hodgkin's disease.
    Hancock SL; Tucker MA; Hoppe RT
    J Natl Cancer Inst; 1993 Jan; 85(1):25-31. PubMed ID: 8416252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast carcinoma in women previously treated for Hodgkin disease: mammographic evaluation.
    Dershaw DD; Yahalom J; Petrek JA
    Radiology; 1992 Aug; 184(2):421-3. PubMed ID: 1320281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of breast cancer according to clinicopathologic features among long-term survivors of Hodgkin's lymphoma treated with radiotherapy.
    Dores GM; Anderson WF; Beane Freeman LE; Fraumeni JF; Curtis RE
    Br J Cancer; 2010 Sep; 103(7):1081-4. PubMed ID: 20842115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast cancer risk in female survivors of Hodgkin's lymphoma: lower risk after smaller radiation volumes.
    De Bruin ML; Sparidans J; van't Veer MB; Noordijk EM; Louwman MW; Zijlstra JM; van den Berg H; Russell NS; Broeks A; Baaijens MH; Aleman BM; van Leeuwen FE
    J Clin Oncol; 2009 Sep; 27(26):4239-46. PubMed ID: 19667275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of breast cancer after Hodgkin's disease.
    Wolden SL; Hancock SL; Carlson RW; Goffinet DR; Jeffrey SS; Hoppe RT
    J Clin Oncol; 2000 Feb; 18(4):765-72. PubMed ID: 10673517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence and risk factors associated with bilateral breast cancer in area with early age diagnosis but low incidence of primary breast cancer: analysis of 10-year longitudinal cohort in Taiwan.
    Kuo WH; Yen AM; Lee PH; Hou MF; Chen SC; Chen KM; Chen TH; Chang KJ
    Breast Cancer Res Treat; 2006 Sep; 99(2):221-8. PubMed ID: 16544057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unilateral and bilateral breast cancer in women surviving pediatric Hodgkin's disease.
    Basu SK; Schwartz C; Fisher SG; Hudson MM; Tarbell N; Muhs A; Marcus KJ; Mendenhall N; Mauch P; Kun LE; Constine LS
    Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):34-40. PubMed ID: 18722264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast Cancer Risk After Radiation Therapy for Hodgkin Lymphoma: Influence of Gonadal Hormone Exposure.
    Krul IM; Opstal-van Winden AWJ; Aleman BMP; Janus CPM; van Eggermond AM; De Bruin ML; Hauptmann M; Krol ADG; Schaapveld M; Broeks A; Kooijman KR; Fase S; Lybeert ML; Zijlstra JM; van der Maazen RWM; Kesminiene A; Diallo I; de Vathaire F; Russell NS; van Leeuwen FE
    Int J Radiat Oncol Biol Phys; 2017 Nov; 99(4):843-853. PubMed ID: 28888722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pilot study evaluating chemotherapy tolerability for breast cancer patients who have received prior treatment and chest radiation for Hodgkin Lymphoma.
    Watson AP; Peterson B; Lee C; Baxstrom K; Turcotte L; Vogel R; Blaes A
    Cancer Treat Res Commun; 2018; 15():1-6. PubMed ID: 30207281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synchronous and metachronous bilateral breast cancer: A long-term experience.
    Ozturk A; Alco G; Sarsenov D; Ilgun S; Ordu C; Koksal U; Nur Pilanci K; Erdogan Z; Izci F; Elbuken F; Agacayak F; Aktepe F; Ozmen V
    J BUON; 2018; 23(6):1591-1600. PubMed ID: 30610782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of second primary cancer in the contralateral breast in women treated for early-stage breast cancer: a population-based study.
    Gao X; Fisher SG; Emami B
    Int J Radiat Oncol Biol Phys; 2003 Jul; 56(4):1038-45. PubMed ID: 12829139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Partial breast brachytherapy as the primary treatment for breast cancer diagnosed after mantle radiation therapy for Hodgkin's disease.
    Chadha M; Yoon H; Feldman S; Shah N; Moore E; Harrison LB
    Am J Clin Oncol; 2009 Apr; 32(2):132-6. PubMed ID: 19307955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Second Cancer Risk Up to 40 Years after Treatment for Hodgkin's Lymphoma.
    Schaapveld M; Aleman BM; van Eggermond AM; Janus CP; Krol AD; van der Maazen RW; Roesink J; Raemaekers JM; de Boer JP; Zijlstra JM; van Imhoff GW; Petersen EJ; Poortmans PM; Beijert M; Lybeert ML; Mulder I; Visser O; Louwman MW; Krul IM; Lugtenburg PJ; van Leeuwen FE
    N Engl J Med; 2015 Dec; 373(26):2499-511. PubMed ID: 26699166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk, characteristics, and prognosis of breast cancer after Hodgkin's lymphoma.
    Veit-Rubin N; Rapiti E; Usel M; Benhamou S; Vinh-Hung V; Vlastos G; Bouchardy C
    Oncologist; 2012; 17(6):783-91. PubMed ID: 22588325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.